Advanced search
1 file | 249.65 KB

From the pergonal project to Kadimastem : a genealogy of Israel’s reproductive-industrial complex

(2017) BIOSOCIETIES. 12(2). p.282-306
Author
Organization
Abstract
In the Israeli ‘start-up nation’ biotechnology has emerged as one of the most thriving knowledge-intensive industries. Particularly the med-tech and repro-tech sector are widely regarded as world class in their ability to develop experimental therapies and medicines based on topnotch ‘pioneering’ biomedical research. These developments have rightly been attributed to the neoliberal turn of the late seventies when Israel started to position itself as significant player in the global health and research market. By exploring the (dis)continuities between Pergonal, a fertility drug developed in the late 1950s by the Israeli scientist Bruno Lunenfeld and the Swiss-Italian pharmaceutical company Serono, and the experimental stem cell therapies that are currently being developed by the Israeli biotech company Kadimastem, this article argues, however, that a much older, but still ongoing history of Zionist settler colonial warfare in Palestine/Israel also lies behind the emergence of Israel’s flourishing reproductive-embryonic industry. A Zionist demographic logic that aims to consolidate a Jewish majority in a Jewish state has created fertile conditions for the emergence of a reproductive-industrial complex in which the interests of a pronatalist Jewish state and a biomedical establishment – consisting of academic entrepreneurs, venture capitalists, biotech companies and pharmaceutical giants – have coalesced. The bodies of Israeli women play a pivotal role in this process, not only as reproducers of the settler nation but also as providers of the raw biological materials that are needed to produce experimental research results and to generate surplus bio-value.
Keywords
reproductive-industrial complex, Palestine/Israel, bio-capitalism, zionism, demography, settler colonialism

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 249.65 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vertommen, Sigrid. 2017. “From the Pergonal Project to Kadimastem : a Genealogy of Israel’s Reproductive-industrial Complex.” Biosocieties 12 (2): 282–306.
APA
Vertommen, S. (2017). From the pergonal project to Kadimastem : a genealogy of Israel’s reproductive-industrial complex. BIOSOCIETIES, 12(2), 282–306.
Vancouver
1.
Vertommen S. From the pergonal project to Kadimastem : a genealogy of Israel’s reproductive-industrial complex. BIOSOCIETIES. 2017;12(2):282–306.
MLA
Vertommen, Sigrid. “From the Pergonal Project to Kadimastem : a Genealogy of Israel’s Reproductive-industrial Complex.” BIOSOCIETIES 12.2 (2017): 282–306. Print.
@article{7045415,
  abstract     = {In the Israeli {\textquoteleft}start-up nation{\textquoteright} biotechnology has emerged as one of the most thriving knowledge-intensive industries. Particularly the med-tech and repro-tech sector are widely regarded as world class in their ability to develop experimental therapies and medicines based on topnotch {\textquoteleft}pioneering{\textquoteright} biomedical research. These developments have rightly been attributed to the neoliberal turn of the late seventies when Israel started to position itself as significant player in the global health
and research market. By exploring the (dis)continuities between Pergonal, a fertility drug developed in the late 1950s by the Israeli scientist Bruno Lunenfeld and the Swiss-Italian pharmaceutical company Serono, and the experimental stem cell therapies that are currently being developed by the Israeli biotech company Kadimastem, this article argues, however, that a much older, but still ongoing history of Zionist settler colonial warfare in Palestine/Israel also lies behind the emergence of Israel{\textquoteright}s flourishing reproductive-embryonic industry. A Zionist demographic logic that aims to consolidate
a Jewish majority in a Jewish state has created fertile conditions for the emergence of a reproductive-industrial complex in which the interests of a pronatalist Jewish state and a biomedical establishment -- consisting of academic entrepreneurs, venture capitalists, biotech companies and pharmaceutical giants -- have coalesced. The bodies of Israeli women play a pivotal role in this process, not only as reproducers of the settler nation but also as providers of the raw biological materials that are needed to produce experimental research results and to generate surplus bio-value.},
  author       = {Vertommen, Sigrid},
  issn         = {1745-8552},
  journal      = {BIOSOCIETIES},
  keyword      = {reproductive-industrial complex,Palestine/Israel,bio-capitalism,zionism,demography,settler colonialism},
  language     = {eng},
  number       = {2},
  pages        = {282--306},
  title        = {From the pergonal project to Kadimastem : a genealogy of Israel{\textquoteright}s reproductive-industrial complex},
  url          = {http://dx.doi.org/10.1057/biosoc.2015.44},
  volume       = {12},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: